D. E. Shaw & Co., Inc. Arbutus Biopharma Corp Transaction History

D. E. Shaw & Co., Inc.

$156 Billion
Q3 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 189,952 shares of ABUS stock, worth $858,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,952

Previous 40,700 366.71%

Holding current value

$858,583

Previous $125,000 589.6%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.08 - $4.9 $459,696 - $731,334	149,252 Added 366.71%	189,952 $862,000
Q2 2025 Aug 14, 2025	BUY	$2.88 - $3.61 $117,216 - $146,927	40,700 New	40,700 $125,000
Q2 2022 Aug 15, 2022	SELL	$1.98 - $3.17 $39,002 - $62,442	-19,698 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.42 - $3.98 $7,748 - $12,743	-3,202 Reduced 13.98%	19,698 $59,000
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $71,219 - $105,569	22,900 New	22,900 $89,000
Q3 2019 Nov 14, 2019	SELL	$1.34 - $2.4 $25,862 - $46,320	-19,300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.46 - $4.44 $41,970 - $127,636	-28,747 Reduced 59.83%	19,300 $40,000
Q4 2018 Feb 14, 2019	SELL	$3.5 - $9.66 $43,781 - $120,836	-12,509 Reduced 20.66%	48,047 $184,000
Q3 2018 Nov 14, 2018	SELL	$7.85 - $12.35 $3.22 Million - $5.06 Million	-409,952 Reduced 87.13%	60,556 $572,000
Q2 2018 Aug 14, 2018	SELL	$5.0 - $7.35 $1.2 Million - $1.76 Million	-239,954 Reduced 33.77%	470,508 $3.44 Million
Q1 2018 May 15, 2018	SELL	$4.4 - $6.05 $2.18 Million - $3 Million	-495,663 Reduced 41.1%	710,462 $3.55 Million
Q4 2017 Feb 14, 2018	SELL	$4.45 - $7.7 $2.44 Million - $4.22 Million	-547,980 Reduced 31.24%	1,206,125 $6.09 Million
Q3 2017 Nov 14, 2017	BUY	$3.4 - $7.0 $5.96 Million - $12.3 Million	1,754,105	1,754,105 $10.9 Million

Others Institutions Holding ABUS

# of Institutions

195

Shares Held

118M

Call Options Held

2.67M

Put Options Held

693K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $678M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account